Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
October 8, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for September 22, 2006 Subscribe to this News Feed      
 

Ortho Evra Contraceptive Patch Associated With Deadly Side Effects

Hissey Kientz, LLP, (http://www.hkllp.com) a toxic tort/mass tort law firm, is investigating Ortho Evra cases involving pulmonary embolisms, strokes, heart attacks and deep venous thrombosis (DVT).

Austin (PRWEB) September 22, 2006 -— The death rate for the Ortho Evra patch is more than three times higher than the rate associated with other contraceptives. The Associated Press, which cited federal death and injury reports, found that many women in their late teens and early twenties died in 2004 from blood clots believed to be related to the birth control patch side effects, and many more survived strokes and other clot-related problems.

The patch, which is applied to the skin, releases hormones including estrogen and progestin. The patch contains roughly the same amount of estrogen as the pill, but the patch sends hormones directly into the bloodstream rather than through the digestive tract, allowing at least 50% more estrogen absorption compared with the pill. More than 4 million women have used the patch since its debut in 2002.

The Food and Drug Administration released a statement in 2005 warning healthcare providers and patients of the increased risk associated with the Ortho Evra patch. The FDA also forced Ortho McNeil, the manufacturer of Ortho Evra, to update its drug label to better notify women of the higher risk of developing blood clots when using the patch compared with the birth control pill (http://www.fda.gov/bbs/topics/news/2005/NEW01262.html).

According to the statement, the FDA is continuing to monitor safety reports regarding the Ortho Evra birth control patch side effects.

Several lawsuits have already been filed by other parties after a report by the Associated Press revealed an internal memo, showing that Ortho McNeil failed to perform a study into the drug’s effects out of fear that results would be unfavorable (case numbers: 3:06 CV 40010, 06-4025-GPM, 06-54-GPM, 06-4020-GPM, 06-4021-GPM).

Hissey Kientz, LLP and its team of experienced mass tort lawyers have been retained in many cases nationwide involving the Ortho Evra birth control patch side effects.

About Hissey Kientz, LLP
Hissey Kientz, LLP is currently handling cases involving people injured by mesothelioma, Zyprexa, Fosamax, Vioxx, Ketek, ReNu with MoistureLoc, heart devices, hormone replacement therapy and other defective drugs. To learn more about Hissey Kientz, LLP and other drug cases, visit Hissey Kientz, LLP (www.hkllp.com) or call (866) 275-4454.

###

See the original story at: http://www.prweb.com/releases/2006/09/prweb434517.htm

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SGFsZi1IYWxmLVNpbmctWmV0YS1JbnNlLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
Mike Hissey
Hissey Kientz LLP
866 275-4454
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright